Literature DB >> 7866986

Adenomas induced by polycyclic aromatic hydrocarbons in strain A/J mouse lung correlate with time-integrated DNA adduct levels.

J A Ross1, G B Nelson, K H Wilson, J R Rabinowitz, A Galati, G D Stoner, S Nesnow, M J Mass.   

Abstract

The induction of DNA adducts and adenomas in the lungs of strain A/J mice has been investigated following the single i.p. administration of each of the following polycyclic aromatic hydrocarbons (PAH): pyrene, dibenz[a,h]anthracene, benzo[a]pyrene, benzo[b]fluoranthene, 5-methylchrysene, and cyclopenta[c,d]pyrene. DNA adducts were measured by 32P-postlabeling at times between 1 and 21 days following injection, while adenomas were counted at 240 days after treatment. Pyrene did not induce either DNA adducts or lung adenomas at any of the doses examined. Each of the remaining PAH induced both adenomas and DNA adducts in a dose-dependent manner, with dibenz[a,h]anthracene > 5-methylchrysene > cyclopenta[c,d]pyrene > benzo[a]pyrene > benzo[b]fluoranthene. DNA adducts reached maximal levels between 3 and 9 days after injection, followed by a gradual decrease. The time-integrated DNA adduct level (TIDAL) was calculated by numerically integrating the areas under the adduct persistence curves extrapolated to 240 days for each PAH at each dose level. This value represents the effective total molecular dose of PAH that was delivered to the lung DNA over the entire course of tumorigenesis. A strong correlation of lung adenoma induction with the TIDAL values was observed for each PAH. The slopes of the tumors versus TIDAL value relationships were essentially identical for 5-methylchrysene, cyclopenta[cd]pyrene, benzo[a]pyrene, and benzo[b]fluoranthene. The slope of this relationship for dibenz[a,h]anthracene was markedly greater. The essentially identical induction of adenomas as a function of TIDAL values for these PAH suggests that the formation and persistence of DNA adducts determines their carcinogenic potency.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7866986

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Toxicokinetics of benzo[a]pyrene in humans: Extensive metabolism as determined by UPLC-accelerator mass spectrometry following oral micro-dosing.

Authors:  Erin Madeen; Lisbeth K Siddens; Sandra Uesugi; Tammie McQuistan; Richard A Corley; Jordan Smith; Katrina M Waters; Susan C Tilton; Kim A Anderson; Ted Ognibene; Kenneth Turteltaub; David E Williams
Journal:  Toxicol Appl Pharmacol       Date:  2018-12-21       Impact factor: 4.219

2.  Pharmacokinetics of [14C]-Benzo[a]pyrene (BaP) in humans: Impact of Co-Administration of smoked salmon and BaP dietary restriction.

Authors:  Jessica M Hummel; Erin P Madeen; Lisbeth K Siddens; Sandra L Uesugi; Tammie McQuistan; Kim A Anderson; Kenneth W Turteltaub; Ted J Ognibene; Graham Bench; Sharon K Krueger; Stuart Harris; Jordan Smith; Susan C Tilton; William M Baird; David E Williams
Journal:  Food Chem Toxicol       Date:  2018-03-05       Impact factor: 6.023

3.  The resveratrol analogue, 2,3',4,5'-tetramethoxystilbene, does not inhibit CYP gene expression, enzyme activity and benzo[a]pyrene-DNA adduct formation in MCF-7 cells exposed to benzo[a]pyrene.

Authors:  Tracey Einem Lindeman; Miriam C Poirier; Rao L Divi
Journal:  Mutagenesis       Date:  2011-06-13       Impact factor: 3.000

4.  Chronic, topical exposure to benzo[a]pyrene induces relatively high steady-state levels of DNA adducts in target tissues and alters kinetics of adduct loss.

Authors:  G Talaska; M Jaeger; R Reilman; T Collins; D Warshawsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

5.  Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP.

Authors:  Monica L Vermillion Maier; Lisbeth K Siddens; Jamie M Pennington; Sandra L Uesugi; Kim A Anderson; Lane G Tidwell; Susan C Tilton; Ted J Ognibene; Kenneth W Turteltaub; Jordan N Smith; David E Williams
Journal:  Environ Int       Date:  2021-12-15       Impact factor: 9.621

6.  Influence of dietary fat type on benzo(a)pyrene [B(a)P] biotransformation in a B(a)P-induced mouse model of colon cancer.

Authors:  Deacqunita L Diggs; Jeremy N Myers; Leah D Banks; Mohammad S Niaz; Darryl B Hood; L Jackson Roberts; Aramandla Ramesh
Journal:  J Nutr Biochem       Date:  2013-12       Impact factor: 6.048

7.  Genotoxicity-related chemistry of human metabolites of benzo[ghi]perylene (B[ghi]P) investigated using electro-optical arrays and DNA/microsome biocolloid reactors with LC-MS/MS.

Authors:  Shenmin Pan; Dandan Li; Linlin Zhao; John B Schenkman; James F Rusling
Journal:  Chem Res Toxicol       Date:  2013-08-08       Impact factor: 3.739

8.  Polycyclic aromatic hydrocarbon-DNA adducts in cervix of women infected with carcinogenic human papillomavirus types: an immunohistochemistry study.

Authors:  M Margaret Pratt; Paul Sirajuddin; Miriam C Poirier; Mark Schiffman; Andrew G Glass; David R Scott; Brenda B Rush; Ofelia A Olivero; Philip E Castle
Journal:  Mutat Res       Date:  2007-05-05       Impact factor: 2.433

Review 9.  Human exposure to selected animal neurocarcinogens: a biomarker-based assessment and implications for brain tumor epidemiology.

Authors:  Dora Il'yasova; Bridget J McCarthy; Serap Erdal; Joanna Shimek; Jennifer Goldstein; Daniel R Doerge; Steven R Myers; Paolo Vineis; John S Wishnok; James A Swenberg; Darell D Bigner; Faith G Davis
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2009-03       Impact factor: 6.393

10.  Immunogenicity of a promiscuous T cell epitope peptide based conjugate vaccine against benzo[a]pyrene: redirecting antibodies to the hapten.

Authors:  Mario T Schellenberger; Nathalie Grova; Sophie Farinelle; Stéphanie Willième; Dominique Revets; Claude P Muller
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.